Mounjaro®
Starting from £179.99/mo
Start journey Learn moreExercising on Wegovy can meaningfully improve your results, but the relationship between semaglutide and physical activity is more nuanced than simply 'move more, lose more'. Wegovy is a prescription-only semaglutide injection that works by reducing appetite and slowing gastric emptying — and how your body responds to exercise shifts once those mechanisms are active. This page covers what the evidence says, what to expect in practice, and how to structure activity safely while on treatment. These are prescription-only medicines; a clinician decides whether they're right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is yes, though not by turbocharging the medicine itself. Wegovy works by acting on GLP-1 receptors to reduce appetite and slow the rate at which food leaves your stomach. Exercise works through entirely separate pathways: it increases energy expenditure, improves insulin sensitivity, and (critically) helps protect the muscle mass that a calorie deficit can otherwise erode.
The STEP 1 trial, published in the New England Journal of Medicine, showed an average weight loss of around 15% over 68 weeks with semaglutide 2.4mg, a GLP-1 receptor agonist you can read more about on our semaglutide page, alongside lifestyle intervention. 'Lifestyle intervention' in that context included dietary guidance and encouraged physical activity. Participants who engaged more actively with both components tended to see stronger outcomes, though the trial was not designed to isolate exercise as a variable.
In practical terms: Wegovy makes it easier to eat less by lowering the hormonal drive to eat. Exercise raises the amount of energy your body needs. The two effects compound. A question our prescribers hear most weeks is whether someone needs to change their exercise routine once they start treatment, and if you want to understand exactly when Wegovy starts working so you can time your expectations around it, that page walks through the early weeks in detail.
For a fuller picture of what exercise is safe and suitable on Wegovy, including timing around injections and managing energy dips, that page goes into the practical detail.
This is the part of the Wegovy-and-exercise conversation that often gets skipped. When you lose weight through calorie restriction alone (which is essentially what Wegovy facilitates) a portion of that loss comes from lean tissue rather than fat. Estimates vary, but research into calorie-restricted weight loss consistently shows that somewhere between 20% and 40% of weight lost without resistance training can come from muscle.
That matters for more than aesthetics. Muscle is metabolically active tissue. Losing it slows your resting metabolic rate, which makes maintaining weight loss harder over time. It also affects strength, balance and long-term joint health.
Resistance training (even two sessions a week with moderate loads) signals to the body that muscle is worth keeping. It does not need to mean a gym. Bodyweight exercises, resistance bands, or any progressive loading stimulus can serve the same function. The NHS's healthy weight guidance highlights strength activity as an integral part of weight management, not an optional extra.
If Wegovy is reducing your appetite significantly, adequate protein intake becomes especially important. Lean tissue preservation depends on it. Practical target: most guidelines suggest around 1.2–1.6g of protein per kilogram of body weight per day during active weight loss, though your prescriber or a registered dietitian can give you a figure tailored to your situation.
Nausea is the most commonly reported early side effect of Wegovy. It typically peaks in the first few days after each dose or dose increase, then settles. For most people it's manageable, but it can genuinely affect training if you push hard while your digestive system is still adjusting.
A few things tend to help. Timing your injection and your hardest training session a few days apart gives the worst of any nausea time to pass. Staying well hydrated matters more than usual, Wegovy slows gastric emptying, and dehydration can compound GI discomfort. Lower-intensity movement like walking, cycling or swimming is usually better tolerated in the first few weeks than high-intensity interval sessions.
Fatigue is reported by some people, particularly early in treatment. If energy levels are lower than usual, reducing workout intensity temporarily is sensible rather than powering through. The NHS medicines page for semaglutide lists the full common side-effect profile, including what warrants medical attention. Side effects that are severe, persistent or include symptoms like upper abdominal pain radiating to the back should always be assessed by a clinician promptly.
For context on the broader timeline of how the medicine establishes itself, our page on how long Wegovy takes to start working and what to expect in those early weeks is worth reading alongside this page.
Some people reach a plateau on Wegovy. Weight loss slows or stalls even with continued treatment and consistent exercise. There are a few reasons this happens: the body adapts its energy expenditure over time, and the biological drive to regain weight is real and well-documented.
Exercise can help push through some of these plateaus by changing body composition even when the scale barely moves, muscle replaces fat at similar weight, so measurements and health markers may be improving when the number on the scale isn't. That said, a genuine plateau on an established maintenance dose, lasting more than a few weeks despite consistent activity and diet, is worth discussing with your prescriber.
There is a separate question about whether Wegovy itself stops working over time, which covers the distinction between the normal slowing of weight loss and a loss of clinical response. Signs that Wegovy is working can also help you track progress beyond the scale.
If you're considering whether Wegovy is the right option for your weight management, check your eligibility with our prescribers. Consultations are free, and a GPhC-registered prescriber reviews every application the same day it's submitted.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.